Twenty‑One a Month: What the Prostate Study Found
The familiar number comes from a questionnaire category. Its link with lower-risk prostate cancer is more specific than the headlines suggest.
“Twenty-one times a month” sounds unusually precise for health advice. It comes from a real study, but the number was the boundary of its highest questionnaire category rather than a frequency researchers established as best.
In the Health Professionals Follow-up Study, men reporting at least 21 ejaculations a month had fewer prostate cancer diagnoses than those reporting four to seven. The clearest association involved lower-risk cancers. The study did not demonstrate a reduction in prostate cancer deaths or an increase in lifespan.
The question men were asked
In 1992, participants estimated their average monthly ejaculation frequency at ages 20–29, ages 40–49 and during the previous year. Ejaculation included intercourse, masturbation and nocturnal emissions. It was not a measure of partner numbers.
An initial report appeared in 2004. Jennifer Rider and colleagues’ 2016 update followed 31,925 men for 18 years, during which 3,839 prostate cancers were diagnosed.
The researchers adjusted for several health and lifestyle differences, including factors related to prostate screening. Nonetheless, this remained an observational study based on self-report, with some participants recalling behaviour from decades earlier.
The size of the association
For reported frequency at ages 40–49, the adjusted hazard ratio was 0.78 for at least 21 ejaculations a month compared with four to seven: a 22% lower relative hazard of diagnosis. The confidence interval ranged from 0.69 to 0.89.
Reported diagnosis rates in those groups were 6.74 and 8.94 per 1,000 person-years, a difference of 2.2 diagnoses. These rates describe the cohort. They cannot be used to predict an individual’s benefit from changing frequency.
Nor did the questionnaire distinguish between 21 and substantially higher numbers. The data cannot establish an optimum within its top category, or prove that 21 is better than 18.
Which cancers were affected?
Prostate cancer ranges from slow-growing tumours that may never cause harm to aggressive disease. That distinction changes the meaning of a lower diagnosis rate.
The association was strongest for low-risk disease. Analyses of tumour subtypes often combined the two higher-frequency groups into a category of at least 13 a month. Findings for aggressive or lethal disease were less convincing.
Avoiding a low-risk diagnosis could spare some men biopsies, anxiety or treatment side effects. That is a possible benefit, rather than something the study directly demonstrated. It is also different from preventing a cancer death.
What later reviews found
A 2018 review of 22 studies found lower prostate cancer odds at a moderate reported frequency of two to four times a week, without a clear linear dose-response. A 2025 update pooled 29 studies and found an inverse association for ejaculation frequency, with an odds ratio of 0.83.
Most studies in those reviews were case-control designs, which are particularly vulnerable to recall and selection bias. Pooling them does not remove those limitations. Measures such as intercourse frequency and number of partners also produced different results, so they should not be treated as interchangeable exposures.
Explore the original categories
The graphic below uses the 2016 estimates for reported frequency at ages 40–49. It is a way to read the study, rather than a health target or personal risk assessment.
Interactive
Explore the study categories
Select a questionnaire category. This shows group associations, not your predicted risk. The readout uses the 2016 multivariable hazard ratios for ages 40–49, plus the absolute rates the paper reported for the reference and top bins.
This is the comparison group. The paper measures other men against this bin, not against zero.
What it means for longevity
There is a repeated association worth investigating, but no trial has assigned ejaculation frequencies and shown that the change prevents fatal prostate cancer. These findings do not provide an estimate of extra years lived.
Readers need not turn a preferred frequency into a quota. The research also gives no basis for increasing partner numbers or taking sexual risks. Screening decisions and symptoms, including urinary changes, require advice based on personal history and risk.
The useful answer to the headline is therefore quite specific: frequent ejaculation was associated with fewer diagnoses, particularly of lower-risk disease. Whether changing frequency causes that reduction, and whether it affects survival, remains uncertain.
Revised with AI assistance on October 6, 2026. This is an editorial revision, not a medical review.
Sources
- Rider JR, Wilson KM, Sinnott JA, Kelly RS, Mucci LA, Giovannucci EL. Ejaculation Frequency and Risk of Prostate Cancer: Updated Results with an Additional Decade of Follow-up. European Urology, 2016;70(6):974–982 (PMID 27033442)
- Leitzmann MF, Platz EA, Stampfer MJ, Willett WC, Giovannucci E. Ejaculation Frequency and Subsequent Risk of Prostate Cancer. JAMA, 2004;291(13):1578–1586
- Giles GG, Severi G, English DR, et al. Sexual factors and prostate cancer. BJU International, 2003;92(3):211–216
- Isaacs JT. Prostatic structure and function in relation to the etiology of prostatic cancer. The Prostate, 1983;4:351–366
- Jian Z, Ye D, Chen Y, Li H, Wang K. Sexual Activity and Risk of Prostate Cancer: A Dose-Response Meta-Analysis. Journal of Sexual Medicine, 2018;15:1300–1309
- Raeisvandi A, Omidi S, Javaheri M, Moradi H, Poorolajal J. Updated dose-response meta-analysis of sexual activity and prostate cancer risk. BMC Cancer, 2025;26:47
- Kokori E, Olatunji G, Isarinade DT, et al. Ejaculation Frequency and Prostate Cancer Risk: A Narrative Review of Current Evidence. Clinical Genitourinary Cancer, 2024;22(3):102043
- Kratzer TB, Mazzitelli N, Goel N, et al. Prostate cancer statistics, 2025. CA: A Cancer Journal for Clinicians, 2025
- Boston University School of Public Health summary of the 2016 Rider paper